News Posts List
Phase II Study of Axitinib in Renal Cancer
08/17/2009
Axitinib has antitumor activity in patients with mRCC refractory to prior VEGF–targeted therapy, including sorafenib.
Overweight is associated with improved survival
08/17/2009
We were able to identify overweight as an independent prognostic marker of improved tumor-specific survival in patients with organ-confined RCC. Basic research is required to resolve the dilemma of why, if a higher BMI predisposes to RCC, it concurrently prolongs survival after patients have undergone (partial) nephrectomy.
New class of antibiotics shows anti-cancer ability
08/17/2009
The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois.
On New Immune Therapy In Combination With Standard Treatment For Kidney Cancer
08/17/2009
Researchers at The Cancer Institute of New Jersey (CINJ) have opened a clinical trial to evaluate whether the standard treatment for a common form of kidney cancer works better by itself or when combined with a certain type of blood cell that comes from a patient's relative.
Cancer lottery: London patients get three times more funding
08/17/2009
Cancer experts said the research, carried out by The Sunday Telegraph, exposed a "grotesque lottery" in which life-and-death decisions were routinely being made by bureaucrats who were "unelected, unaccountable and unqualified" to make the rulings.
Concert for Kyle
08/15/2009
Event to honor Kyle Blakeman, who lost his battle at the age of 13 to Renal Medullary Carcinoma.
Understanding How Americans View Health Care Reform
08/14/2009
At a personal level, most Americans do not think the current reform legislation will improve their health care or lower their costs.
UK Health Czars Defend Kidney Cancer Drug Rationing
08/11/2009
Gail Balding, 62, died last November to kidney cancer following a prolonged fight to get Sutent, a life-prolonging drug. She was refused the drug three times after appealing.
Immune drug linked to cancer
08/10/2009
The drugs include infliximab and etanercept, which are used for the treatment of juvenile rheumatoid arthritis (JRA), Crohn's disease and other inflammatory diseases.
EU Approves Everolimus
08/08/2009
The European Commission has approved everolimus (Afinitor) tablets for the treatment of patients with advanced renal cell carcinoma (RCC) whose disease progressed on or after treatment with vascular endothelial growth factor (VEGF)-targeted therapy.
News Feed